Eurofins Scientific (ERRFY) Stock Price, News & Analysis

Company Overview

Eurofins Scientific (OTCMKTS:ERRFY) is a global leader in bioanalytical testing services, offering a broad portfolio of laboratory solutions to clients in the pharmaceutical, food, environmental, consumer products and agriculture sectors. The company’s core activities include analytical testing, method development, contract research and regulatory support, designed to ensure product safety, quality and compliance with international standards.

Founded in 1987 by Dr. Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions. Today it operates a network of more than 900 laboratories across over 50 countries, serving customers in Europe, North America, Asia-Pacific and beyond. Its service lines encompass pharmaceutical and biotech testing, food and feed testing, environmental monitoring, genomics, consumer product testing and agroscience services, enabling it to address a wide range of industry-specific analytical challenges.

Under the leadership of founder and CEO Dr. Gilles Martin, Eurofins emphasizes scientific excellence, regulatory expertise and operational efficiency. The company employs tens of thousands of scientists, technicians and support staff who work collaboratively to deliver fast turnaround times and robust data integrity. Eurofins continues to invest in new technologies and laboratory infrastructure to support its mission of improving health, safety and quality for businesses, regulators and consumers worldwide.

Key Stats

• Today's Range: $11.99 to $11.99
• 50-Day Range: $11.99 to $11.99
• 52-Week Range: $3.03 to $30.00
• Volume: 100 shs
• Average Volume: 12,799 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Services To The Health Industry
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ERRFY
• CIK: N/A
• Web: N/A
• Phone: (522) 618-5320
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A